Related Experiment Video

Updated: May 10, 2026

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation
04:43

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

Published on: May 23, 2025

Propranolol is more effective than pulsed dye laser and cryosurgery for infantile hemangiomas

Shinji Kagami1, Yoshihiro Kuwano, Sayaka Shibata

  • 1Department of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan, kagamis-tky@umin.ac.jp.

European Journal of Pediatrics
|July 2, 2013
PubMed

Insights

Propranolol offers a superior, safe treatment for infantile hemangiomas compared to traditional methods. Early propranolol intervention significantly reduces hemangioma size and redness with minimal side effects.

Area of Science:

  • Pediatric Dermatology
  • Pharmacology
  • Vascular Anomalies

Background:

  • Infantile hemangiomas are common benign vascular tumors in infants.
  • Traditional treatments like laser and cryosurgery have limitations.
  • Propranolol, a nonselective beta-blocker, shows promise for hemangioma treatment.

Purpose of the Study:

  • To compare the efficacy of propranolol versus conventional therapies for infantile hemangiomas.
  • To evaluate propranolol's safety profile in infants with hemangiomas.

Main Methods:

  • Prospective study comparing propranolol (2 mg/kg/day) to pulsed dye laser/cryosurgery.
  • Involved 15 infants treated with propranolol and 12 controls.
  • Monitored infants via ECG, echocardiogram, chest X-ray, and regular vital sign checks.

Main Results:

  • Propranolol demonstrated significantly faster involution and reduced redness.
  • No adverse events like hypoglycemia, hypotension, or bradycardia were observed.
  • Blinded volume measurements and photographs confirmed propranolol's superior efficacy.

Conclusions:

  • Propranolol is highly effective with a favorable safety profile for infantile hemangiomas.
  • Early treatment with propranolol may decrease disfigurement.
  • Propranolol should be considered a first-line therapy for infantile hemangiomas.
Abstract

Related Concept Videos

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...